Average Co-Inventor Count = 5.07
ph-index = 32
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (49 from 1,536 patents)
2. Boehringer Ingelheim Pharma Gmbh & Co Kg (15 from 194 patents)
3. Boehringer Ingelheim Pharma Kg (7 from 149 patents)
4. Boehringer Ingelheim International Pharma Gmbh & Co. Kg (1 from 1 patent)
5. Neurocrine Biosciences, Inc. (120 patents)
72 patents:
1. 12479827 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
2. 11760745 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
3. 10695334 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
4. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
5. 10307402 - Azabenzimidazole derivatives as agonists of the AMP-activated protein kinase
6. 10202383 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
7. 10053471 - Azabenzimidazole derivatives
8. 10023574 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
9. 9926308 - N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
10. 9597310 - Indanyloxydihydrobenzofuranylacetic acids
11. 9556175 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions
12. 9492436 - Azabenzimidazole derivatives
13. 9422312 - Azabenzimidazole derivatives
14. 9321791 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
15. 9108964 - 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions